Evolution of Multidrug Resistance in Plasmodium falciparum: a Longitudinal Study of Genetic Resistance Markers in the Greater Mekong Subregion.
Greater Mekong subregion
Plasmodium falciparum
genetic resistance markers
Journal
Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061
Informations de publication
Date de publication:
17 11 2021
17 11 2021
Historique:
pubmed:
14
9
2021
medline:
15
12
2021
entrez:
13
9
2021
Statut:
ppublish
Résumé
Increasing resistance in Plasmodium falciparum to artemisinins and their artemisinin combination therapy (ACT) partner drugs jeopardizes effective antimalarial treatment. Resistance is worst in the Greater Mekong subregion. Monitoring genetic markers of resistance can help to guide antimalarial therapy. Markers of resistance to artemisinins (
Identifiants
pubmed: 34516247
doi: 10.1128/AAC.01121-21
pmc: PMC8597770
doi:
Substances chimiques
Antimalarials
0
Genetic Markers
0
Multidrug Resistance-Associated Proteins
0
Protozoan Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0112121Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome
ID : 101148/Z/13/Z
Organisme : Wellcome Trust
ID : 106698/B/14/Z
Pays : United Kingdom
Références
Lancet Infect Dis. 2016 Mar;16(3):357-65
pubmed: 26774243
Lancet Infect Dis. 2017 Feb;17(2):174-183
pubmed: 27818097
Mol Biochem Parasitol. 1995 Jan;69(1):135-8
pubmed: 7723784
Clin Infect Dis. 2016 Sep 15;63(6):784-791
pubmed: 27313266
Lancet Infect Dis. 2018 Mar;18(3):337-345
pubmed: 29398391
Genomics. 2009 Jan;93(1):22-6
pubmed: 18822366
Lancet Infect Dis. 2017 May;17(5):491-497
pubmed: 28161569
Lancet Infect Dis. 2017 Dec;17(12):1233
pubmed: 29173875
Elife. 2020 May 12;9:
pubmed: 32394893
Malar J. 2017 Apr 19;16(1):152
pubmed: 28420389
Lancet Infect Dis. 2019 Sep;19(9):943-951
pubmed: 31345709
Lancet Infect Dis. 2021 Aug;21(8):1120-1128
pubmed: 33864801
Nat Commun. 2018 Aug 17;9(1):3314
pubmed: 30115924
Genome Biol Evol. 2017 Jun 1;9(6):1673-1686
pubmed: 28854635
Antimicrob Agents Chemother. 2009 Apr;53(4):1509-15
pubmed: 19164150
Lancet Infect Dis. 2017 Feb;17(2):164-173
pubmed: 27818095
Malar J. 2020 May 13;19(1):181
pubmed: 32404110
Emerg Infect Dis. 2017 Apr;23(4):715-717
pubmed: 28322709
Am J Trop Med Hyg. 1999 Jun;60(6):1019-23
pubmed: 10403336
Trends Parasitol. 2021 Jan;37(1):15-24
pubmed: 33060063
Lancet. 2004 Jul 31-Aug 6;364(9432):438-447
pubmed: 15288742
Lancet Infect Dis. 2020 Dec;20(12):1470-1480
pubmed: 32679084
PLoS Med. 2019 Feb 15;16(2):e1002745
pubmed: 30768615
Int J Parasitol Drugs Drug Resist. 2019 Apr;9:16-22
pubmed: 30580023
Lancet. 2020 Apr 25;395(10233):1345-1360
pubmed: 32171078
BMC Med. 2015 Dec 22;13:305
pubmed: 26695060
N Engl J Med. 2014 Jul 31;371(5):411-23
pubmed: 25075834
Lancet Infect Dis. 2019 Sep;19(9):952-961
pubmed: 31345710
Lancet. 2018 May 12;391(10133):1916-1926
pubmed: 29703425
Biomol Detect Quantif. 2017 Nov 01;14:7-18
pubmed: 29255685
Nat Microbiol. 2017 Mar 13;2:17031
pubmed: 28288098